List of Excipients in API LATANOPROST
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing LATANOPROST
Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
---|---|---|---|---|---|
PFIZER LABORATORIES DIV PFIZER INC | XALATAN | latanoprost | 0013-8303 | BENZALKONIUM CHLORIDE | |
PFIZER LABORATORIES DIV PFIZER INC | XALATAN | latanoprost | 0013-8303 | SODIUM CHLORIDE | |
PFIZER LABORATORIES DIV PFIZER INC | XALATAN | latanoprost | 0013-8303 | SODIUM PHOSPHATE, DIBASIC, ANHYDROUS | |
PFIZER LABORATORIES DIV PFIZER INC | XALATAN | latanoprost | 0013-8303 | WATER | |
Sun Pharmaceutical Industries Inc | XELPROS | latanoprost | 47335-317 | BORIC ACID | |
Sun Pharmaceutical Industries Inc | XELPROS | latanoprost | 47335-317 | CASTOR OIL | |
Sun Pharmaceutical Industries Inc | XELPROS | latanoprost | 47335-317 | EDETATE DISODIUM | |
>Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing LATANOPROST
Company | Ingredient | NDC | Excipient |
---|---|---|---|
MWI | latanoprost | 13985-610 | BENZALKONIUM CHLORIDE |
MWI | latanoprost | 13985-610 | SODIUM CHLORIDE |
MWI | latanoprost | 13985-610 | SODIUM PHOSPHATE, DIBASIC, ANHYDROUS |
MWI | latanoprost | 13985-610 | SODIUM PHOSPHATE, MONOBASIC |
MWI | latanoprost | 13985-610 | WATER |
Akorn | latanoprost | 17478-625 | BENZALKONIUM CHLORIDE |
Akorn | latanoprost | 17478-625 | SODIUM CHLORIDE |
>Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for LATANOPROST
Excipient focus: BENZALKONIUM CHLORIDE
LATANOPROST drug variants containing BENZALKONIUM CHLORIDE
LATANOPROST drug variants not containing BENZALKONIUM CHLORIDE
Company | Ingredient | NDC |
---|---|---|
Sun Pharmaceutical Industries Inc | latanoprost | 47335-317 |
A-S Medication Solutions | latanoprost | 50090-7062 |
Viatris Specialty LLC | latanoprost | 58151-419 |
Sandoz Inc | latanoprost | 61314-547 |
Thea Pharma Inc | latanoprost ophthalmic solution 0.005% | 82584-003 |
>Company | >Ingredient | >NDC |
Excipient focus: BORIC ACID
LATANOPROST drug variants containing BORIC ACID
Company | Ingredient | NDC |
---|---|---|
Sun Pharmaceutical Industries Inc | latanoprost | 47335-317 |
>Company | >Ingredient | >NDC |
LATANOPROST drug variants not containing BORIC ACID
Excipient focus: CARBOMER HOMOPOLYMER TYPE B
LATANOPROST drug variants containing CARBOMER HOMOPOLYMER TYPE B
Company | Ingredient | NDC |
---|---|---|
Thea Pharma Inc | latanoprost ophthalmic solution 0.005% | 82584-003 |
>Company | >Ingredient | >NDC |
LATANOPROST drug variants not containing CARBOMER HOMOPOLYMER TYPE B
Excipient focus: CASTOR OIL
LATANOPROST drug variants containing CASTOR OIL
Company | Ingredient | NDC |
---|---|---|
Sun Pharmaceutical Industries Inc | latanoprost | 47335-317 |
>Company | >Ingredient | >NDC |
LATANOPROST drug variants not containing CASTOR OIL
Excipient focus: EDETATE DISODIUM
LATANOPROST drug variants containing EDETATE DISODIUM
Company | Ingredient | NDC |
---|---|---|
Sun Pharmaceutical Industries Inc | latanoprost | 47335-317 |
Thea Pharma Inc | latanoprost ophthalmic solution 0.005% | 82584-003 |
>Company | >Ingredient | >NDC |
LATANOPROST drug variants not containing EDETATE DISODIUM
Excipient focus: EDETATE SODIUM
LATANOPROST drug variants containing EDETATE SODIUM
Company | Ingredient | NDC |
---|---|---|
Bausch & Lomb Incorporated | latanoprostene bunod | 24208-504 |
>Company | >Ingredient | >NDC |
LATANOPROST drug variants not containing EDETATE SODIUM
Excipient focus: GLYCERIN
LATANOPROST drug variants containing GLYCERIN
Company | Ingredient | NDC |
---|---|---|
Bausch & Lomb Incorporated | latanoprostene bunod | 24208-504 |
>Company | >Ingredient | >NDC |
LATANOPROST drug variants not containing GLYCERIN
Excipient focus: HYDROCHLORIC ACID
LATANOPROST drug variants containing HYDROCHLORIC ACID
Company | Ingredient | NDC |
---|---|---|
Sun Pharmaceutical Industries Inc | latanoprost | 47335-317 |
>Company | >Ingredient | >NDC |
LATANOPROST drug variants not containing HYDROCHLORIC ACID
Excipient focus: POLYETHYLENE GLYCOL 4000
LATANOPROST drug variants containing POLYETHYLENE GLYCOL 4000
Company | Ingredient | NDC |
---|---|---|
Thea Pharma Inc | latanoprost ophthalmic solution 0.005% | 82584-003 |
>Company | >Ingredient | >NDC |
LATANOPROST drug variants not containing POLYETHYLENE GLYCOL 4000
Excipient focus: POLYOXYL 15 HYDROXYSTEARATE
LATANOPROST drug variants containing POLYOXYL 15 HYDROXYSTEARATE
Company | Ingredient | NDC |
---|---|---|
Sun Pharmaceutical Industries Inc | latanoprost | 47335-317 |
>Company | >Ingredient | >NDC |
LATANOPROST drug variants not containing POLYOXYL 15 HYDROXYSTEARATE
Excipient focus: POLYOXYL 40 HYDROGENATED CASTOR OIL
LATANOPROST drug variants containing POLYOXYL 40 HYDROGENATED CASTOR OIL
Company | Ingredient | NDC |
---|---|---|
Thea Pharma Inc | latanoprost ophthalmic solution 0.005% | 82584-003 |
>Company | >Ingredient | >NDC |
LATANOPROST drug variants not containing POLYOXYL 40 HYDROGENATED CASTOR OIL
Excipient focus: POLYSORBATE 80
LATANOPROST drug variants containing POLYSORBATE 80
Company | Ingredient | NDC |
---|---|---|
Bausch & Lomb Incorporated | latanoprostene bunod | 24208-504 |
>Company | >Ingredient | >NDC |
LATANOPROST drug variants not containing POLYSORBATE 80
Excipient focus: POTASSIUM SORBATE
LATANOPROST drug variants containing POTASSIUM SORBATE
Company | Ingredient | NDC |
---|---|---|
Sun Pharmaceutical Industries Inc | latanoprost | 47335-317 |
>Company | >Ingredient | >NDC |
LATANOPROST drug variants not containing POTASSIUM SORBATE
Excipient focus: PROPYLENE GLYCOL
LATANOPROST drug variants containing PROPYLENE GLYCOL
Company | Ingredient | NDC |
---|---|---|
Sun Pharmaceutical Industries Inc | latanoprost | 47335-317 |
>Company | >Ingredient | >NDC |
LATANOPROST drug variants not containing PROPYLENE GLYCOL
Excipient focus: SODIUM BORATE
LATANOPROST drug variants containing SODIUM BORATE
Company | Ingredient | NDC |
---|---|---|
Sun Pharmaceutical Industries Inc | latanoprost | 47335-317 |
>Company | >Ingredient | >NDC |
LATANOPROST drug variants not containing SODIUM BORATE
Excipient focus: SODIUM CHLORIDE
LATANOPROST drug variants containing SODIUM CHLORIDE
LATANOPROST drug variants not containing SODIUM CHLORIDE
Company | Ingredient | NDC |
---|---|---|
Sun Pharmaceutical Industries Inc | latanoprost | 47335-317 |
Thea Pharma Inc | latanoprost ophthalmic solution 0.005% | 82584-003 |
Bausch & Lomb Incorporated | latanoprostene bunod | 24208-504 |
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM HYDROXIDE
LATANOPROST drug variants containing SODIUM HYDROXIDE
Company | Ingredient | NDC |
---|---|---|
Sun Pharmaceutical Industries Inc | latanoprost | 47335-317 |
Thea Pharma Inc | latanoprost ophthalmic solution 0.005% | 82584-003 |
>Company | >Ingredient | >NDC |
LATANOPROST drug variants not containing SODIUM HYDROXIDE
Excipient focus: SODIUM PHOSPHATE, DIBASIC ANHYDROUS
LATANOPROST drug variants containing SODIUM PHOSPHATE, DIBASIC ANHYDROUS
Company | Ingredient | NDC |
---|---|---|
Rebel Distributors Corp | latanoprost | 21695-986 |
Physicians Total Care Inc | latanoprost | 54868-6254 |
Dispensing Solutions Inc | latanoprost | 68258-8976 |
>Company | >Ingredient | >NDC |
LATANOPROST drug variants not containing SODIUM PHOSPHATE, DIBASIC ANHYDROUS
Excipient focus: SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
LATANOPROST drug variants containing SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
LATANOPROST drug variants not containing SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
Excipient focus: SODIUM PHOSPHATE, MONOBASIC
LATANOPROST drug variants containing SODIUM PHOSPHATE, MONOBASIC
Company | Ingredient | NDC |
---|---|---|
MWI | latanoprost | 13985-610 |
Akorn | latanoprost | 17478-625 |
Rebel Distributors Corp | latanoprost | 21695-986 |
Bausch & Lomb Incorporated | latanoprost | 24208-463 |
A-S Medication Solutions | latanoprost | 50090-1920 |
Physicians Total Care Inc | latanoprost | 54868-6254 |
FDC Limited | latanoprost | 55545-1010 |
>Company | >Ingredient | >NDC |
LATANOPROST drug variants not containing SODIUM PHOSPHATE, MONOBASIC
Excipient focus: SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE
LATANOPROST drug variants containing SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE
LATANOPROST drug variants not containing SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE
Excipient focus: SORBITOL
LATANOPROST drug variants containing SORBITOL
Company | Ingredient | NDC |
---|---|---|
Thea Pharma Inc | latanoprost ophthalmic solution 0.005% | 82584-003 |
>Company | >Ingredient | >NDC |
LATANOPROST drug variants not containing SORBITOL
Excipient focus: WATER
LATANOPROST drug variants containing WATER
LATANOPROST drug variants not containing WATER
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.